There is a large market for alternative hormone therapies, driven in large part by traditional medicine shying away from prescribing. How do doctors counsel patients on the risks of these compounded products and talk about safe alternatives? What studies do we have to inform our counseling, and how to transition someone back to FDA-regulated HRT? Dr. Rebecca Dunsmoor-Su and Dr. Ghazaleh Moayedi discuss and answer physician questions.
Add A Comment